ACE and congenital rubella syndrome: The identification of RAAS overactivity in CRS provides further rationale for using RAAS inhibitors (ACE inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists) to break the vicious cycle, though caution is needed as these can acutely worsen renal function.